secwatch.observer — SEC 8-K summary
======================================

Issuer:     BAXTER INTERNATIONAL INC (BAX)
CIK:        0000010456
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0001628280-25-006558
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baxter Q4 adj EPS $0.58 beats guidance; Q4 sales $2.75B (+2% CC)
----------------------------------------------------------------

- Q4 sales from continuing ops $2.75B, up 1% reported / 2% constant currency, exceeding guidance.
- GAAP diluted EPS loss ($0.95); adjusted EPS $0.58, ahead of company's guidance range.
- Full-year 2024 sales $10.64B (+3% reported & CC); adjusted EPS $1.89, exceeded guidance.
- Sale of Kidney Care business completed, streamlining Baxter for next stage of growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10456/000162828025006558/0001628280-25-006558-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10456/000162828025006558/bax-20250220.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-006558

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer